{"name":"PhotoMedex, Inc.","slug":"photomedex","ticker":"PHMD","exchange":"OTC","domain":"photomedex.com","description":"PhotoMedex, Inc. is a medical technology company focused on dermatology. The company offers a range of products, including photodynamic therapy (PDT) systems and aesthetic treatments. PhotoMedex operates in the US and internationally, with a presence in the dermatology market. The company has a portfolio of products that cater to various dermatological needs.","hq":"Irvine, CA","founded":0,"employees":"","ceo":"Dennis M. McGrath","sector":"MedTech / Dermatology","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$12M","metrics":{"revenue":20000000,"revenueGrowth":-100,"grossMargin":0,"rdSpend":1249000,"netIncome":-2044000,"cash":4804000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2018"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2020-02-25","type":"earnings","headline":"PhotoMedex Reports Fourth Quarter and Full Year 2019 Financial Results","summary":"PhotoMedex reported its financial results for the fourth quarter and full year 2019, with revenue of $24.4 million and a net loss of $2.4 million.","drugName":"","sentiment":"neutral"},{"date":"2018-10-01","type":"deal","headline":"PhotoMedex Completes Acquisition of XTRAC","summary":"PhotoMedex acquired XTRAC, a leading manufacturer of excimer lasers for the treatment of psoriasis and vitiligo.","drugName":"XTRAC","sentiment":"positive"}],"realNews":[{"date":"2021-07-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2021-03-29","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2021-03-03","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2020-11-30","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2020-10-13","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2020-09-08","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2020-03-17","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2020-03-05","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2020-02-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2020-02-24","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2020-02-10","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2020-01-07","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2019-11-13","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2019-11-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":["Cutera","Lumenis","Cynosure"],"therapeuticFocus":["Dermatology","Aesthetics"],"financials":{"source":"sec_edgar+yahoo","revenue":41000,"revenuePeriod":"2018-12-31","revenueHistory":[{"value":41000,"period":"2018-12-31"},{"value":163541000,"period":"2014-12-31"},{"value":38878000,"period":"2014-12-31"},{"value":35611000,"period":"2014-09-30"},{"value":38977000,"period":"2014-06-30"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":1249000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-2044000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":4804000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}